Pursue Wealth Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$592K Hold
4,248
0.35% 55
2025
Q4
$521K Hold
4,248
0.25% 61
2025
Q3
$472K Hold
4,248
0.26% 63
2025
Q2
$471K Hold
4,248
0.27% 65
2025
Q1
$476K Hold
4,248
0.29% 66
2024
Q4
$392K Hold
4,248
0.22% 64
2024
Q3
$356K Hold
4,248
0.19% 73
2024
Q2
$291K Hold
4,248
0.16% 77
2024
Q1
$311K Hold
4,248
0.18% 73
2023
Q4
$344K Sell
4,248
-124
-3% -$9.65K 0.22% 67
2023
Q3
$328K Hold
4,372
0.23% 71
2023
Q2
$337K Hold
4,372
0.21% 75
2023
Q1
$363K Hold
4,372
0.25% 72
2022
Q4
$375K Hold
4,372
0.29% 72
2022
Q3
$270K Hold
4,372
0.19% 84
2022
Q2
$270K Hold
4,372
0.17% 92
2022
Q1
$267K Hold
4,372
0.11% 115
2021
Q4
$317K Buy
+4,372
New +$301K 0.12% 110

Other funds holding GILD

Pursue Wealth Partners's GILD Position: Q1 2026 in Review

Pursue Wealth Partners held its Gilead Sciences (GILD) position steady in Q1 2026 at 4,248 shares worth $592K. The position accounts for 0.35% of the portfolio, ranked #55.

Pursue Wealth Partners first reported a position in GILD in Q4 2021 and has held it in 18 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Pursue Wealth Partners held 4,248 shares of Gilead Sciences worth $592K as of Q1 2026.
  • Pursue Wealth Partners left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.35% of Pursue Wealth Partners's portfolio in Q1 2026, its #55 holding.
  • Pursue Wealth Partners first reported a position in Gilead Sciences in Q4 2021 and has held it in 18 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Pursue Wealth Partners's 13F filing for Q1 2026, filed 8 Apr 2026.